Select country change
Shopping cart (0 , 0,00 ) Menu Search
Manufactured by BioVendor

hsa-miR-142-5p miREIA

  • Regulatory status:RUO
  • Type:miREIA – miRNA enzyme immunoassay
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price

New RDM0013H 96 wells (1 kit)
PubMed Product Details
Technical Data


miREIA – miRNA enzyme immunoassay


Whole blood

Sample Requirements

10 µl/well


Store the complete kit at 2 – 8 °C. Under these conditions, all components are stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

12.5 – 0.39 amol/μl

Limit of Detection

0.13 amol/μl

Intra-assay (Within-Run)

n = 8,
CV = 2.6%

Inter-assay (Run-to-Run)

n = 5,
CV = 13.3%

Spiking Recovery


Dilutation Linearity




  • It is intended for research use only
  • The total assay time is less than 2.5 hours
  • The kit measures hsa-miR-142-5p isolated from human blood
  • Assay format is 96 wells
  • Standard is synthetic miRNA-based
  • Components of the kit are provided ready to use, concentrated or dried

Research topic

Cardiovascular disease, Oncology, Renal disease

References to Summary

References to miR-142-5p

  • TSANG, Felice Ho-Ching, et al. MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility. Frontiers of medicine, 2015, 9.3: 331-343.
  • ZHANG, X., et al. Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Annals of oncology, 2011, 22.10: 2257-2266.
  • LANDGRAF, Pablo, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell, 2007, 129.7: 1401-1414.
  • DANGER, Richard, et al. Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection. PloS one, 2013, 8.4: e60702.
  • ANGLICHEAU, Dany, et al. MicroRNA expression profiles predictive of human renal allograft status. Proceedings of the National Academy of Sciences, 2009, 106.13: 5330-5335.
  • LIU, Lingqi, et al. MicroRNA-142-5p promotes cell growth and migration in renal cell carcinoma by targeting BTG3. American journal of translational research, 2017, 9.5: 2394.
  • SHARMA, Salil, et al. Repression of miR‐142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy. EMBO molecular medicine, 2012, 4.7: 617-632.
  • BARSANTI, Cristina, et al. Differential regulation of microRNAs in end-stage failing hearts is associated with left ventricular assist device unloading. BioMed research international, 2015, 2015.
  • VOELLENKLE, Christine, et al. MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiological genomics, 2010, 42.3: 420-426.
Related Products Documents